Study at a glance
How were vitamin D signals and the skin barrier studied in animals?
Animal experiments examined vitamin D-related signals and the skin barrier. One applied calcitriol, the active vitamin D hormone, to mice with dermatitis, or skin inflammation, brought on for the experiment. Another compared rats with no vitamin D receptor, rats with an altered receptor and normal rats. The receptor helps cells respond to vitamin D. These are different tests from giving ordinary supplements to people.
Did active vitamin D applied to mouse skin improve the barrier?
Over four days, treated dermatitis mice lost less water through the skin and showed better restriction of a test substance within the skin. Dermatitis scores also improved. Some defence and inflammatory signals changed, but not all did. A lower dose did not show the same benefit, healthy skin did not improve in the same way, and treated normal skin showed mild redness.
What happened when rats lacked a normal vitamin D receptor?
Rats without the receptor developed hair loss, abnormal skin structure and poorer barrier measurements. Rats retaining a receptor with greatly reduced vitamin D binding preserved several features, although they were not identical to normal rats. This suggests some receptor functions differ from its usual response to vitamin D. More activity in barrier-related genes did not necessarily mean a better functioning barrier.
Do these animal findings establish an eczema treatment for people?
The experiment applying treatment to the skin was short and used small male groups. The genetic changes affected the whole animal, so local skin effects could not be fully separated from other body changes. Human wound-signalling work adds a separate mechanism, not proof of the same treatment benefit. These studies do not establish long-term safety, treatment for human eczema, faster skin replacement, or a plan for sunlight exposure or taking supplements by mouth.
Read the full article below ↓Mouse and rat experiments connect vitamin D-related signalling with epidermal permeability, inflammatory markers and keratinocyte maintenance. Topical active hormone and genetic changes to the receptor test different parts of that relationship. They should be interpreted alongside, rather than substituted for, human wound-signalling evidence. The companion appraisal is Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Study Summary.
Barrier function needs functional measurements
Umehara and colleagues studied male NC/Nga mice with experimentally induced dermatitis. Detergent disruption and mite-antigen exposure produced a skin condition in which barrier function and inflammation could be examined together. After dermatitis was established, the investigators applied calcitriol or its ethanol vehicle for four days. The principal treatment was 1 nmol in 150 microlitres per day.
This is an experiment with topical active hormone. It is not a trial of oral cholecalciferol, a test of sunlight exposure or a study that selected animals according to low serum vitamin D. That distinction matters for Vitamin D and Skin: changing a local pharmacological exposure and correcting nutritional insufficiency are different interventions, even when they involve related molecules.
Transepidermal water loss, abbreviated TEWL, was lower in treated dermatitis mice on the later treatment days, including days three and four. Dermatitis scores also improved. A separate tracer experiment examined movement of biotin applied from the dermal side and found better restriction below the upper epidermis after treatment. Water loss and tracer location therefore supplied functional observations beyond changes in messenger RNA alone.
Protein, transcript and inflammatory responses were selective
The study examined junction-related and barrier-associated proteins by staining and measured selected transcripts. These endpoints did not all behave identically. Protein localisation can change without the same direction or magnitude of messenger-RNA change, and a transcript does not reveal whether its product is correctly assembled into a functional tissue structure. The experiment supports selected responses rather than uniform restoration of every barrier component.
Antimicrobial-related transcription was also selective. Defb1 and Defb2 increased, whereas Defb3 and Defb14 were already elevated in dermatitis and were not further increased by calcitriol. Camp was not induced in this model. These differences are important when connecting Vitamin D and Barrier Immunity with Vitamin D and Antimicrobial Peptides. A general claim that all antimicrobial defences rose would misrepresent the experiment.
Il13 and Il33 decreased under the tested dermatitis conditions, but Il4 did not show the same response. In normal skin, Tslp increased. The result is therefore not a universal suppression of every inflammatory signal in every skin state. It illustrates why Vitamin D and Inflammatory Signalling needs the cell state, stimulus and selected endpoint to remain visible.
Dose, duration and assay details limit the treatment claim
The supplementary lower-dose comparison did not show the same benefit with 0.1 nmol. Healthy mice did not show an equivalent improvement in barrier function, and treated normal C57BL/6J skin showed mild redness. The dermatitis challenge continued during the treatment schedule. The result is not simply a measurement of recovery after the provoking exposure had ended, nor evidence that more topical hormone is always preferable.
The experiment was short and used small groups of male mice. Randomisation and blinding were not clearly established for every assessment. Several microscopic fields from a specimen should not be counted as the same number of independent animals. The study does not settle long-term safety, systemic calcium effects or the effectiveness of a treatment regimen in people with eczema.
The printed primer table gives identical sequences for Flg and Actb. That creates an assay-reconstruction problem for the corresponding gene-specific quantitative PCR interpretation. The functional water-loss and tracer results, and the separately measured protein observations, do not become the same assay because of that table issue. This review therefore does not use a specific filaggrin transcript result as the decisive evidence for barrier improvement.
A receptor-genetic experiment asks a different question
Kise and colleagues compared wild-type rats, rats lacking VDR and knock-in rats with R270L/H301Q substitutions that greatly reduce ligand binding. The binding characterisation came from earlier work; the new comparison should not be described as proving complete absence of every possible ligand interaction. Its value is in separating the consequences of losing the receptor from those of retaining a substantially altered receptor.
VDR-knockout rats developed alopecia, epidermal abnormalities including cysts and hyperkeratosis, and impaired barrier measurements. The knock-in rats were closer to wild type in several of these phenotypes. This supports a contribution from receptor functions that may not require normal ligand binding. It does not demonstrate that supplying extra vitamin D would reverse all effects of receptor loss.
TEWL means were higher in knockout animals at the examined ages, but the reported wild-type versus knockout difference was statistically significant only at thirty weeks. The evidence should not be strengthened into a claim of a significant difference at every age. An age-related pattern also does not identify the first cellular event that produced the later tissue phenotype.
More expression does not necessarily mean a better barrier
At thirty weeks, whole-skin RNA sequencing used three male rats per genotype. Epidermal keratin and cornified-envelope genes were increased in knockout skin despite its poorer barrier phenotype, while hair-keratin expression declined. Increased expression of a barrier-associated gene can therefore accompany disordered tissue. It may reflect altered cell composition or a compensatory response rather than successful restoration of function.
The knock-in animals were not identical to wild type. Hair-related and pathway-level differences remained. The proliferation-associated gene Mki67 was higher in knockout than wild-type skin, but the supplement also reports a knock-in versus wild-type difference. Describing every knock-in result as normal would erase informative distinctions. The main comparison supports a more limited conclusion: retaining this altered receptor preserved several tissue features that were disrupted by complete receptor deletion.
Supplementary proteomics compared one female wild-type rat with one female VDR-knockout rat; there was no knock-in proteomic comparison. Those measurements can generate hypotheses but cannot provide a replicated estimate of genotype effects or independent confirmation of the male RNA-sequencing result. Sex, age, specimen composition and the measured molecular layer should remain separate features of the evidence rather than being merged into a single larger sample.
Whole-body genetics does not isolate keratinocyte causation
Both the knockout and knock-in are whole-body genetic models. Mineral physiology and other systemic differences can influence skin alongside local receptor activity. The comparison is therefore not equivalent to deleting VDR only in keratinocytes while holding every circulating influence constant. It supports receptor-related tissue maintenance, with the relative local and systemic contributions incompletely separated.
Vitamin D Receptors supplies the relevant distinction between ligand availability and response machinery. Vitamin D and Cell Differentiation adds a second distinction: changes in the identity and maturation of cells affect the final tissue. Neither receptor abundance nor a selected differentiation marker measures the complete cycle of proliferation, migration, terminal differentiation and shedding.
The genetic study did not directly quantify that complete replacement cycle. Histology and gene-expression profiles contribute evidence about maintenance and cellular organisation; they should not be renamed as a measured epidermal turnover rate. Following labelled cell populations over time would address a different question and help distinguish compensation from an initiating defect.
Human wound signalling adds a separate immune contribution
Schauber and colleagues examined injury-related vitamin D activation, TLR2-associated responses and antimicrobial peptide expression using human skin and cellular experiments. That work supplies an immune-signalling contribution to the broader skin subject. It does not repeat the mouse water-loss experiment or establish that the same topical regimen improves a human permeability barrier.
The fuller account appears in Skin Vitamin D Synthesis, Local Activation and Signalling: Full Evidence Review. Its activation-dependent response helps explain why Vitamin D Activation matters locally. The absence of Camp induction in the mouse dermatitis experiment should not be hidden by borrowing a positive human cathelicidin result from a different setting.
Likewise, expression of an antimicrobial molecule is not itself a measurement of infection prevention. A functional infection claim would require an organism-related outcome, while a healing claim would require an appropriate measure of closure or restored tissue function over time. The selected studies illuminate components of defence without proving that every component improves together.
The two animal approaches therefore answer complementary questions. An acute intervention asks whether an established tissue state can change over four days. A lifelong genetic comparison asks what develops when a receptor is absent or altered throughout the animal. A favourable response in the first does not demonstrate that the ligand-dependent mechanism explains every abnormality in the second. Conversely, preservation of several features in the knock-in rats does not mean that ligand-responsive signalling is unnecessary for every skin function. Keeping the interventions separate allows the apparently different results to inform the same physiological account without making them falsely contradictory.
The water-loss and biotin-tracer experiments also examine different directions of movement. Outward water loss reflects one aspect of the epidermal barrier, while dermal tracer restriction tests passage towards the upper layers under the assay conditions. Agreement supports a barrier-related interpretation, but neither measurement directly quantifies the entry of a pathogen from the surface or the elimination of that pathogen by immune cells.
Clinical interpretation requires the same distinctions
The context in Vitamin D and Sun concerns cutaneous production, a different exposure from either topical calcitriol or genetic receptor alteration. These experiments cannot establish a sunlight regimen. Nor can the topical dose be converted into an oral recommendation by assuming that the same amount reaches the skin through a regulated circulation.
A human intervention would need a defined population, an appropriate comparator, baseline exposure information and a prespecified barrier or disease endpoint. A useful mechanistic extension would separately test receptor dependence of the topical response and distinguish local from systemic effects in the genetic comparison. These are concrete unresolved questions, rather than evidence that the observed mouse responses are clinically sufficient.
Conclusion
The studies support selected connections between vitamin D-related biology, skin permeability and keratinocyte maintenance. Topical calcitriol improved particular short-term endpoints in a mouse dermatitis model, while genetic comparisons showed that receptor loss and impaired ligand binding are not equivalent. Human wound-signalling evidence adds a distinct immune mechanism. Together they justify a conditional physiological account, with clinical treatment, long-term safety and complete epidermal turnover still requiring direct evidence.
Sources and publication details
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin. Kise S and colleagues. International Journal of Molecular Sciences. 2025;26(1):422. DOI: 10.3390/ijms26010422. PMID: 39796272.
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.
Related reading
1α, 25-Dihydroxyvitamin D3 and the vitamin D receptor regulates ΔNp63α levels and keratinocyte proliferation
1α, 25-dihydroxyvitamin D3 (VD3), a secosteriod that has been explored as an anti-cancer agent, was also shown to promote cell survival.
Original paper ↗Read more →20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes
The side chain of vitamin D3 is hydroxylated in a sequential manner by cytochrome P450scc (CYP11A1) to form 20-hydroxycholecalciferol, which can induce growth arrest and differentiation of both primary and immortalized epidermal keratinocytes.
Original paper ↗Read more →25-Hydroxyvitamin D status, vitamin D intake, and skin cancer risk: a systematic review and dose-response meta-analysis of prospective studies
Sun exposure is a major environmental risk factor for skin cancers and is also an important source of vitamin D.
Original paper ↗Read more →8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D3-induced growth inhibition without affecting 1,25-dihydroxyvitamin D3-stimulated differentiation of primary mouse epidermal keratinocytes
Epidermal keratinocytes continuously proliferate and differentiate to form the mechanical and water permeability barrier that makes terrestrial life possible.
Original paper ↗Read more →Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Original paper ↗Read more →Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin
Since Vdr-KO rats also showed abnormalities in the skin, the relationship between alopecia and skin abnormalities was examined.
Original paper ↗Read more →LPS-induced Vitamin D Receptor Decrease in Oral Keratinocytes Is Associated With Oral Lichen Planus
In human specimen studies, VDR levels of oral mucosal epithelia from OLP patients decreased substantially accompanied with robust TNFα and miR-346 induction, compared to the normal tissues.
Original paper ↗Read more →Renin Promotes STAT4 Phosphorylation to Induce IL-17 Production in Keratinocytes of Oral Lichen Planus
Interleukin-17 (IL-17) is highly expressed in the epithelial layer of oral lichen planus (OLP), but the underlying mechanism for IL-17 overexpression remains unknown.
Original paper ↗Read more →RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene Signature
IL-36 cytokines have recently emerged as mediators of inflammation in autoimmune conditions including psoriasis vulgaris (PsV) and generalized pustular psoriasis (GPP).
Original paper ↗Read more →Sericin coated thin polymeric films reduce keratinocyte proliferation via the mTOR pathway and epidermal inflammation through IL17 signaling in psoriasis rat model
Therapeutic treatment forms can play significant roles in resolving psoriatic plaques or promoting wound repair in psoriatic skin.
Original paper ↗Read more →The Over-Irradiation Metabolite Derivative, 24-Hydroxylumister-ol3, Reduces UV-Induced Damage in Skin
The current study investigated the photoprotective properties of the major over-irradiation metabolite, 24(OH)L3, in human primary keratinocytes and human skin explants.
Original paper ↗Read more →UV‐induced DNA Damage in Skin is Reduced by CaSR Inhibition
In this study, we investigated whether the CaSR is involved more directly in protection from UV damage in studies of human keratinocytes in primary culture and in mouse skin studied in vivo.
Original paper ↗Read more →Vitamin D Promotes Mucosal Barrier System of Fish Skin Infected with Aeromonas hydrophila through Multiple Modulation of Physical and Immune Protective Capacity
The vertebrate mucosal barrier comprises physical and immune elements, as well as bioactive molecules, that protect organisms from pathogens.
Original paper ↗Read more →Vitamin D receptor-deficient keratinocytes-derived exosomal miR-4505 promotes the macrophage polarization towards the M1 phenotype
The vitamin D receptor (VDR) has a low level of expression in the keratinocytes of patients with psoriasis and plays a role in the development of the disease.
Original paper ↗Read more →Vitamin D signaling regulates oral keratinocyte proliferation in vitro and in vivo
We examined the role of 1,25(OH)2D3 in regulating proliferation and differentiation in cultured oral keratinocytes and on the oral epithelium in vivo.
Original paper ↗Read more →Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Study Summary
Summary of animal skin-barrier experiments: selective calcitriol responses, receptor-dependent maintenance and the limits of human treatment claims.
Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review
Gut, lung and skin studies compared: what vitamin D signalling reveals about barrier failure, and what human trials do and do not establish.
Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study Summary
Compare gut, lung and skin barrier findings in plain English, including differences between experimental models and human supplement trials.
Read more →Non-Skeletal Roles of Vitamin D in Skin, Gut, and Cardiovascular Disease: Focus on Epithelial Barrier Function and Immune Regulation in Chronic Disease
Vitamin D is increasingly recognized as a key regulator of epithelial barrier integrity and mucosal immune homeostasis, with implications extending far beyond skeletal health.
Original paper ↗Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Study Summary
Summary of intestinal VDR, Notch-related barrier responses and microbial metabolism, with direct human permeability and microbiota trial findings.
Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Original sources
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Publication details
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin
Since Vdr-KO rats also showed abnormalities in the skin, the relationship between alopecia and skin abnormalities was examined.
Publication details
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin. Kise S and colleagues. International Journal of Molecular Sciences. 2025;26(1):422. DOI: 10.3390/ijms26010422. PMID: 39796272.
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism
Published in Schauber J and colleagues. Journal of Clinical Investigation (2007).
Publication details
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.